Lv3
264 积分 2022-07-11 加入
Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non–small cell lung cancer
19天前
已完结
Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer
19天前
已完结
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
19天前
已完结
Pan-cancer single-cell landscape of tumor-infiltrating T cells
24天前
已完结
DNA methylation profiles of cancer-related fatigue associated with markers of inflammation and immunometabolism
25天前
已完结
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study
26天前
已完结
Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefit
1个月前
已完结
A Highly Sensitive and Specific Non‐Invasive Test through Genome‐Wide 5‐Hydroxymethylation Mapping for Early Detection of Lung Cancer
1个月前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
2个月前
已完结
Tumor intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer
2个月前
已完结
皖公网安备34019202002308
